Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STSP-0902 in Neurotrophic Keratitis
NCT06975748Phase 2Recruiting
- Sponsor
- Staidson Biopharmaceutical
- Start
- Jun 2025
- Primary completion
- Apr 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of STSP-0902 in neurotrophic keratitis (NK), sponsored by Staidson Biopharmaceutical. Started Jun 2025; status: recruiting.
02
Drugs
STSP-0902
03
Conditions
neurotrophic keratitis (NK)
Beyond the preview
Go deeper on NCT06975748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06975748.